B

Brain+ A/S
CSE:BRAINP

Watchlist Manager
Brain+ A/S
CSE:BRAINP
Watchlist
Price: 0.01 DKK 4.17% Market Closed
Market Cap: 11.3m DKK

Brain+ A/S
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Brain+ A/S
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
B
Brain+ A/S
CSE:BRAINP
EPS (Diluted)
kr0
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
NNIT A/S
CSE:NNIT
EPS (Diluted)
kr0
CAGR 3-Years
N/A
CAGR 5-Years
-65%
CAGR 10-Years
-41%
M
Monsenso A/S
CSE:MONSO
EPS (Diluted)
kr0
CAGR 3-Years
40%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
No Stocks Found

Brain+ A/S
Glance View

Market Cap
11.3m DKK
Industry
Health Care

Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.

BRAINP Intrinsic Value
HIDDEN
Show

See Also

What is Brain+ A/S's EPS (Diluted)?
EPS (Diluted)
-0 DKK

Based on the financial report for Dec 31, 2024, Brain+ A/S's EPS (Diluted) amounts to -0 DKK.

What is Brain+ A/S's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
41%

Over the last year, the EPS (Diluted) growth was 83%. The average annual EPS (Diluted) growth rates for Brain+ A/S have been 41% over the past three years .

Back to Top